Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

T & B Bioclone
Profile last edited on: 1/23/07      CAGE:       UEI:

Business Identifier: Development and production of immunoassay kits for cancer detection
Year Founded
1985
First Award
1988
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4786 Enser Road
Eden, NY 14057
   (716) 992-2633
   nejat.egilmez@louisville.edu
   N/A
Location: Single
Congr. District: 27
County: Erie

Public Profile

With close ties to the University in Buffalo, T & B Bioclone is involved in the development and production of immunoassay kits for cancer detection.

Extent of SBIR involvement

User Avatar
Phase I Awards
5
Phase II Awards
2
Conversion Rate
40.00%
Phase I Dollars
$443,500
Phase II Dollars
$491,381
Total Awarded
$934,881

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 1 NIH $115,652
Project Title: Interleukin-10 Microspheres for Therapy of IBD
2002 2 NIH $419,229
Project Title: Bioadhesive Microspheres For Colon Cancer Therapy
1990 1 NIH $50,000
Project Title: Human monoclonal anitbodies produced in scid mice
1989 1 NIH $50,000
Project Title: Cell separation by immunoflotation
1989 2 NIH $300,000
Project Title: Monoclonal Antibody (MoAb) Conjugates for Therapy and Diagnosis

Key People / Management

  Richard Bankert -- President

  Nejat K Egilmez

  Raymond J Kelleher

Company News

There are no news available.